Beta-Blockers in Asymptomatic Coronary Artery Disease No Benefit or No Evidence?

被引：11
|
作者：
Steg, Philippe Gabriel [1 ,2 ,3 ,4 ]
De Silva, Ranil [4 ,5 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75018 Paris, France
[2] Univ Paris Diderot, Paris, France
[3] INSERM, U 1148, Paris, France
[4] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England
[5] Royal Brompton & Harefield NHS Fdn Trust, NIHR, Cardiovasc Biomed Res Unit, London, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 03期
关键词：
beta-blockers; coronary artery disease; ACUTE MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; CARDIOVASCULAR EVENTS; HEART; CARVEDILOL; METOPROLOL; MORTALITY; THERAPY; OUTPATIENTS; MANAGEMENT;
D O I：
10.1016/j.jacc.2014.04.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [1] Current use of beta-blockers in patients with coronary artery disease
    Andreasen, Charlotte
    Andersson, Charlotte
    TRENDS IN CARDIOVASCULAR MEDICINE, 2018, 28 (06) : 382 - 389
  • [2] Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
    Lee, Pil Hyung
    Park, Gyung-Min
    Han, Seungbong
    Kim, Yong-Giun
    Lee, Jong-Young
    Roh, Jae-Hyung
    Lee, Jae-Hwan
    Kim, Young-Hak
    Lee, Seung-Whan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Redondo-Dieguez, Alfredo
    Gonzalez-Ferreiro, Rocio
    Lopez-Lopez, Andrea
    Bouzas-Cruz, Noelia
    Castineira-Busto, Maria
    Pena Gil, Carlos
    Maria Garcia-Acuna, Jose
    Ramon Gonzalez-Juanatey, Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (07): : 585 - 591
  • [4] Beta-blockers: recognising the assets in relation to coronary artery disease
    Kendall, MJ
    BASIC RESEARCH IN CARDIOLOGY, 2000, 95 : 31 - 36
  • [5] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Cruz Rodriguez, Jose B.
    Alkhateeb, Haider
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (03)
  • [6] Beta-blockers do not provide survival benefit in a population with angiographic coronary artery disease without myocardial infarction or reduced ejection fraction: A meta-analysis
    Jaradat, Mohammad
    Shetty, Kartika
    Hasan, Mohanad
    Malik, Ali O.
    Shawo, Alexandra
    Ahsan, Chowdhury
    Yoo, Ji Won
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 976 - 980
  • [7] Is Pretreatment with Beta-Blockers Beneficial in Patients with Acute Coronary Syndrome?
    Cuculi, F.
    Radovanovic, D.
    Pedrazzini, G.
    Regli, M.
    Urban, P.
    Stauffer, J. C.
    Erne, P.
    CARDIOLOGY, 2010, 115 (02) : 91 - 97
  • [8] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Jose B. Cruz Rodriguez
    Haider Alkhateeb
    Current Cardiology Reports, 2020, 22
  • [9] A critical evidence-based summary of the use of beta-blockers in stable coronary artery disease
    Cartwright, Andrea Lynn
    Wilby, Kyle John
    AVICENNA, 2014, (01):
  • [10] Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry
    Stepinska, Janina
    Marona, Milosz
    Greenlaw, Nicola
    Steg, Gabriel
    KARDIOLOGIA POLSKA, 2014, 72 (11) : 1156 - 1164
12345